Brief: Adamis Pharmaceuticals Reports Full Year 2021 Financial Results And Provides Corporate Update
31/03/2022 22:25
March 31 (Reuters) - Adamis Pharmaceuticals Corp ADMP.O :
* ADAMIS PHARMACEUTICALS REPORTS FULL YEAR 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* ADAMIS PHARMACEUTICALS CORP - CASH AND EQUIVALENTS AS OF
DECEMBER 31, 2021, TOTALED APPROXIMATELY $23.2 MILLION
Source text for Eikon: ID:nGNXbsmQT7
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update